Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...

Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.

Where (and how) you wear your health tracker can impact your data accuracy. Here's what researchers say matters most.

A Previously Banned Apple Watch Health Feature Is Now Here to Stay ...

One particularly problematic sleep disorder is sleep apnea, and it is not rare. The condition affects nearly 1 billion people ...

CMF today launched its third smartwatch—the CMF Watch Pro 3. The smartwatch is a major upgrade to the Watch Pro 2 that was launched in 2024, bringing a brighter screen, improved heart rate, sleep ...

This condition’s prevalence is rising worldwide, and it is very treatable, but disparities in access to care remain.

Edwards Lifesciences on April 23 reported that its largest business, transcatheter aortic valve replacement (TAVR), ...

Worldwide Medical Supply has announced its FingerbPulse Fingertip Pulse Oximeter, a blood oxygen monitor designed for ...

Worldwide Medical Supply announces the release of its Finger Pulse Oximeter, which provides instant SpO2 and pulse rate ...

Introduction Traumatic brain injury (TBI), a leading cause of global morbidity and mortality, has notably poorer outcomes in ...

Masimo's NeoPODS study found its SET pulse oximetry technology delivered consistent accuracy in critically ill newborns across all skin tones, addressing longstanding concerns over racial bias in ...